Our team received a game-changing dataset from vendors, comprising extensive lung CT scans. The objective was to automatically detect and segment cancerous lung nodules using a Deep Learning model. The client required an advanced solution to identify patients most likely to have malignant nodules, optimizing recruitment and ensuring a homogeneous study population. Additionally, the model aimed to quantify tumor volume changes with higher precision than manual assessments, improving treatment efficacy evaluation.
Our experts implemented a Convolutional Neural Network (CNN) to extract critical imaging features potentially linked to genetic or molecular markers. This approach not only enhanced nodule detection but also provided deeper insights into tumor biology, paving the way for personalized treatment strategies.
The project was a success, ensuring the quality and consistency of medical data used for training the Deep Learning model. A rigorous validation process on independent datasets confirmed the model’s reliability and clinical utility. Additionally, our team addressed potential biases in data and model predictions while maintaining patient privacy and informed consent throughout the study.
Our team received a game-changing dataset from vendors, comprising extensive lung CT scans. The objective was to automatically detect and segment cancerous lung nodules using a Deep Learning model. The client required an advanced solution to identify patients most likely to have malignant nodules, optimizing recruitment and ensuring a homogeneous study population. Additionally, the model aimed to quantify tumor volume changes with higher precision than manual assessments, improving treatment efficacy evaluation.
Our experts implemented a Convolutional Neural Network (CNN) to extract critical imaging features potentially linked to genetic or molecular markers. This approach not only enhanced nodule detection but also provided deeper insights into tumor biology, paving the way for personalized treatment strategies.
The project was a success, ensuring the quality and consistency of medical data used for training the Deep Learning model. A rigorous validation process on independent datasets confirmed the model’s reliability and clinical utility. Additionally, our team addressed potential biases in data and model predictions while maintaining patient privacy and informed consent throughout the study.
Headquartered in New Jersey, Rang Technologies has dedicated over a decade delivering innovative solutions and best talent to help businesses get the most out of the latest technologies in their digital transformation journey. Rang Technologies has grown to become a global leader in Analytics, Data Science, Artificial Intelligence, Machine Learning, Salesforce CRM, Cloud, DevOps, Internet of Things (IoT), Cybersecurity, IT Consulting and Staffing, and Corporate Training. Our clients, which include Fortune 500 to Start-up companies, come from a wide array of industries, including pharmaceuticals, healthcare, retail, technology, BFSI, media, automobile, manufacturing, and several others. Our clients know they can rely on Rang Technologies to deliver customized and comprehensive digital solutions and talent to complement their business and technical objectives.
